Highlights ReproCELL Incorporated

Equities

4978

JP3974770004

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-02 am EDT			5-day change	1st Jan Change
139 ^JPY	-2.11%		+2.96%	-20.57%

2023	ReproCELL Incorporated announced that it has received ¥5.3 million in funding from Morgan Stanley MUFG Securities Co., Ltd.	CI
2023	ReproCELL Incorporated announced that it expects to receive ¥5.3 million in funding	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ReproCELL Incorporated Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-12	CI
REPROCELL Signs Agreement to Prospectively Collect Samples for IFF's Microbiome Study	22-04-20	CI
Hoth Therapeutics Extends Partnership Agreement with REPROCELL	21-10-19	CI
Reprocell Signs Strategic Collaboration Agreement with TEXCELL to Boost Its GMP iPSC	21-09-01	CI
Curato Japan Co., Ltd. agreed to acquire unknown stake in Repro Curato Co., Ltd. from ReproCELL Incorporated.	21-07-15	CI
Lantern Pharma Selects Reprocell Inc. to Provide Preclinical Screening and Biomarker Discovery Services for Portfolio of Targeted Oncology Drugs	19-10-29	CI
Neucyte, Inc and Reprocell Enters into Distribution Partnership	19-09-25	CI
ReproCELL Incorporated acquired the remaining 0.87% stake in BioServe Biotechnologies Pvt Ltd. for INR 0.85 million.	19-07-09	CI
ReproCELL, Inc. completed the acquisition of 98.28% stake in BioServe Biotechnologies Pvt Ltd from Cancer Genetics, Inc..	18-04-26	CI
ReproCELL, Inc. concluded a contract to acquire 98.28% stake in BioServe Biotechnologies Pvt Ltd from Cancer Genetics, Inc. for $1.9 million.	18-04-25	CI
Q Therapeutics, Inc. Announces Joint Venture With ReproCELL, Inc	18-04-23	CI
Q Therapeutics, Inc. Announces Research Collaboration with REPROCELL Inc	17-12-13	CI
BioServe Biotechnologies, Ltd. cancelled the acquisition of Stemgent Inc. and Biopta Inc. from Biopta Ltd and ReproCELL, Inc..	17-07-31	CI
BioServe Biotechnologies, Ltd. agreed to acquire Stemgent Inc. and Biopta Inc. from Biopta Ltd and ReproCELL, Inc..	16-07-31	CI
ReproCELL, Inc. completed the acquisition of Biopta Ltd from Scottish Co-Investment Fund of The Scottish Investment Bank, Braveheart Investment Group plc, David Cameron Bunton, Christopher Robert Hiller, and Maria Virginia Borletti.	15-12-14	CI
ReproCELL, Inc. agreed to acquire Biopta Ltd from Scottish Co-Investment Fund of The Scottish Investment Bank, Braveheart Investment Group plc, David Cameron Bunton, Christopher Robert Hiller, and Maria Virginia Borletti for JPY 1 billion.	15-11-23	CI
Cancer Genetics to Power Next-Generation Sequencing Services for ReproCELL	15-05-26	CI
3-D Matrix, Ltd. and ReproCELL Announce Launch of the Comprehensive Research and Development Project for Creating the Culture Product Kit Using 'ReproHepato' Human iPS Cell Derived Hepatocyte	14-12-01	CI
ReproCELL, Inc. completed the acquisition of 85.2% stake in Reinnervate Limited from Northstar Ventures, Parkwalk UK Technology Fund II, a fund managed by Parkwalk Advisors Ltd, Jules Green, Simon Constantine, Simon Pilcher and Durham University.	14-08-04	CI
ReproCELL, Inc. completed the acquisition of 67.6% stake in BioServe Biotechnologies, Ltd. from Rama Modali and Ventureast Trustee Company Pvt Ltd.	14-08-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights ReproCELL Incorporated

Equities

4978

JP3974770004

Highlights

Filters